Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01262105 · ClinicalTrials.gov registry record · NA

Device to Reduce Surgery Site Contamination - Spine

A NA study, sponsored by Nimbic Systems.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT01262105: Completed NA study, sponsored by Nimbic Systems.

NCT01262105 is a NA study that has completed, run by Nimbic Systems. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01262105, a NA study, has completed, sponsored by Nimbic Systems.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g. bacteria) present at a surgery site during spinal procedures.

Primary Outcome

CFU culture counts for samples taken in surgery.

Interventions

  • DEVICE Air Barrier System Device

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2009-11
Est. Completion 2010-12
Phase NA
Nimbic Systems

4 total trials

What the finished NCT01262105 record still lists

NCT01262105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Air Barrier System Device is the first listed.

NCT01262105 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01262105 about?

NCT01262105 is a clinical study titled "Device to Reduce Surgery Site Contamination - Spine". The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g. bacteria) present at a surgery site during spinal procedures.

What is the current status of trial NCT01262105?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2009-11. Estimated completion is 2010-12.

What interventions are being tested in trial NCT01262105?

The interventions under investigation include: Air Barrier System Device (DEVICE).

Who is sponsoring clinical trial NCT01262105?

This trial is sponsored by Nimbic Systems, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01262105's enrollment target sits among peer trials

23 1755th of 2000 higher than 245 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01262105, the US trial registry maintained by the National Library of Medicine. NCT01262105 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.